Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
CONMED Corporation is a medical devices business based in the US. CONMED Corporation shares (CNMD) are listed on the NYSE and all prices are listed in US Dollars. CONMED Corporation employs 3,400 staff and has a trailing 12-month revenue of around 0.00.
Our top pick for
Long-term investors
Our top pick for
Beginners
Our top pick for
Active traders
| Latest market close | $127.29 |
|---|---|
| 52-week range | $105.50 - $158.88 |
| 50-day moving average | $141.77 |
| 200-day moving average | $136.71 |
| Wall St. target price | $160.60 |
| PE ratio | 69.8915 |
| Dividend yield | $0.8 (0.59%) |
| Earnings per share (TTM) | $1.94 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $127.29 from 2022-01-20
| 1 week (2022-01-13) | -6.77% |
|---|---|
| 1 month (2021-12-22) | -9.00% |
| 3 months (2021-10-22) | -12.87% |
| 6 months (2021-07-22) | -4.51% |
| 1 year (2021-01-22) | 5.81% |
|---|---|
| 2 years (2020-01-22) | 16.40% |
| 3 years (2019-01-22) | 90.73% |
| 5 years (2017-01-20) | 192.89% |
Valuing CONMED Corporation stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of CONMED Corporation's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
CONMED Corporation's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 70x. In other words, CONMED Corporation shares trade at around 70x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
CONMED Corporation's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 5.29. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into CONMED Corporation's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
CONMED Corporation's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $166.4 million.
The EBITDA is a measure of a CONMED Corporation's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $989.5 million |
|---|---|
| Operating margin TTM | 10.08% |
| Gross profit TTM | $477 million |
| Return on assets TTM | 3.57% |
| Return on equity TTM | 8.65% |
| Profit margin | 6.29% |
| Book value | $25.85 |
| Market capitalisation | $4 billion |
TTM: trailing 12 months
Dividend payout ratio: 26.85% of net profits
Recently CONMED Corporation has paid out, on average, around 26.85% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0.59% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), CONMED Corporation shareholders could enjoy a 0.59% return on their shares, in the form of dividend payments. In CONMED Corporation's case, that would currently equate to about $0.8 per share.
While CONMED Corporation's payout ratio might seem fairly standard, it's worth remembering that CONMED Corporation may be investing much of the rest of its net profits in future growth.
CONMED Corporation's most recent dividend payout was on 4 January 2022. The latest dividend was paid out to all shareholders who bought their shares by 13 December 2021 (the "ex-dividend date").
CONMED Corporation's shares were split on a 3:2 basis on 9 September 2001. So if you had owned 2 shares the day before before the split, the next day you'd have owned 3 shares. This wouldn't directly have changed the overall worth of your CONMED Corporation shares – just the quantity. However, indirectly, the new 33.3% lower share price could have impacted the market appetite for CONMED Corporation shares which in turn could have impacted CONMED Corporation's share price.
Over the last 12 months, CONMED Corporation's shares have ranged in value from as little as $105.4981 up to $158.8772. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while CONMED Corporation's is 1.5722. This would suggest that CONMED Corporation's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for minimally invasive procedures worldwide. It offers orthopedic surgery products, including sports medicine products comprising powered resection instruments, arthroscopes, reconstructive systems, tissue repair sets, and metal and bioabsorbable implants, as well as related disposable products and fluid management systems; powered surgical instruments for use in bone orthopedic, arthroscopic, oral/maxillofacial, podiatric, spinal, and cardiothoracic surgeries; sports biologics and tissue products; and surgical visualization products. The company markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands. It also offers general surgery products, such as clinical insufflation, smoke evacuation, electrosurgical, and endomechanical products; and endoscopic technologies, including diagnostic and therapeutic products for use in gastroenterology procedures, and products for the treatment of diseases of the biliary structures, as well as cardiac monitoring products comprising ECG and EEG electrodes, and cardiac defibrillation pads. The company markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. CONMED Corporation was incorporated in 1970 and is headquartered in Largo, Florida. .
Read our expert analysis on Vigorus and how the token will perform in the future.
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq.
Starting Jan. 18, every household can order up to four free at-home COVID-19 tests. But you’ll have to wait for them.
While there are no known plans to expand the acceptance of Doge to its cars, customers can already buy a Tesla with Bitcoin.
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq.
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq.
Donut earns up to 10% APY, but you must have an iOS device.
Monie offers 5% APY on deposits, but funds aren’t insured and the interface is buggy.
We’ve rounded up stats on some of the most popular COVID test stocks, along with information on how they compare and how to invest.
Record vehicle deliveries cause the Tesla stock price to move close to all-time highs.